Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001023175-08-000053
Filing Date
2008-04-14
Accepted
2008-04-14 08:26:25
Documents
5
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED DECEMBER 31, 2007 hb0710ke.htm 10-K 822834
2 CONSULTING AGREEMENT: HOLMES & NEWPORT CAPITAL CONSULTANTS exh101capital.htm EX-10.1 19746
3 PRINCIPAL EXECUTIVE OFFICER CERTIFICATION hbio07decex311.htm EX-31.1 5787
4 CHIEF FINANCIAL OFFICER CERTIFICATION hbio07decex312.htm EX-31.2 5732
5 SECTION 1350 CERTIFICATION hbio07decex321.htm EX-32.1 2193
  Complete submission text file 0001023175-08-000053.txt   857829
Mailing Address 8655 EAST VIA DE VENTURA SUITE G 200 SCOTTSDALE AZ 85258
Business Address 8655 EAST VIA DE VENTURA SUITE G 200 SCOTTSDALE AZ 85258 480-436-1010
HOLMES BIOPHARMA, INC. (Filer) CIK: 0001080426 (see all company filings)

EIN.: 880412635 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31129 | Film No.: 08753591
SIC: 5400 Retail-Food Stores